Pharmacological and genetic access to astrocytic cholesterol programs in human neural cells

Astrocyte-neuron interactions coordinate cholesterol metabolism, cell adhesion, and synaptic gene expression1,2, and related gene expression programs decline together in schizophrenia3. Whether pharmacological or genetic perturbations can selectively engage components of this coordinated biology was unknown. Here we combine genetically diverse cultures of human stem-cell-derived neurons and astrocytes, pharmacological profiling, genetic association mapping and CRISPR interference to examine these biological programs. In stem-cell-derived astrocyte mono-cultures, the antipsychotic clozapine induced a focused transcriptional response involving cholesterol biosynthesis and export, and drove an increase in intracellular and secreted cholesterol. This response overlapped with the cholesterol-related component of the astrocytic response to neuronal contact seen in neuron-astrocyte co-cultures, but did not extend to synaptic cell-adhesion genes. In neuron-astrocyte co-cultures, clozapine also increased neuronal firing. Across individual cell donors, cholesterol-pathway induction by clozapine was broadly shared but varied in magnitude. Gene-expression patterns in untreated donors were associated with differential responses to clozapine and the liver X receptor agonist GW3965. Common genetic variation influenced expression of several cholesterol-related genes, including a clozapine-dependent association of HSD17B7 expression with nearby genetic variants. Independently, repression of LDLR induced coordinated expression of cholesterol-biosynthesis genes in astrocytes that overlapped with astrocyte responses to clozapine and neuronal contact. These findings identify shared cholesterol-related transcriptional responses to pharmacological and genetic perturbations and link common genetic variation to distinct features of cholesterol-pathway responses.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.16.767064
Primary Topic
Cholesterol and Lipid Metabolism
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Pharmacological and genetic access to astrocytic cholesterol programs in human neural cells

Dhara Liyanage, Noah L. Pettinari, Matthew Tegtmeyer, Ajay Nadig et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Cholesterol and Lipid Metabolism
preprint

Pharmacological and genetic access to astrocytic cholesterol programs in human neural cells

Dhara Liyanage, Noah L. Pettinari, Matthew Tegtmeyer, Ajay Nadig, Adrianna Maglieri, Ralda Nehme, Vy Ngo, He Jax Xu, Derek Hawes, Steven A. McCarroll, Emily R. Peirent, Kiku Ichihara, Sonia Bolshakova, Marina Hogan, Jim Nemesh
preprint en

Abstract

Astrocyte-neuron interactions coordinate cholesterol metabolism, cell adhesion, and synaptic gene expression1,2, and related gene expression programs decline together in schizophrenia3. Whether pharmacological or genetic perturbations can selectively engage components of this coordinated biology was unknown. Here we combine genetically diverse cultures of human stem-cell-derived neurons and astrocytes, pharmacological profiling, genetic association mapping and CRISPR interference to examine these biological programs. In stem-cell-derived astrocyte mono-cultures, the antipsychotic clozapine induced a focused transcriptional response involving cholesterol biosynthesis and export, and drove an increase in intracellular and secreted cholesterol. This response overlapped with the cholesterol-related component of the astrocytic response to neuronal contact seen in neuron-astrocyte co-cultures, but did not extend to synaptic cell-adhesion genes. In neuron-astrocyte co-cultures, clozapine also increased neuronal firing. Across individual cell donors, cholesterol-pathway induction by clozapine was broadly shared but varied in magnitude. Gene-expression patterns in untreated donors were associated with differential responses to clozapine and the liver X receptor agonist GW3965. Common genetic variation influenced expression of several cholesterol-related genes, including a clozapine-dependent association of HSD17B7 expression with nearby genetic variants. Independently, repression of LDLR induced coordinated expression of cholesterol-biosynthesis genes in astrocytes that overlapped with astrocyte responses to clozapine and neuronal contact. These findings identify shared cholesterol-related transcriptional responses to pharmacological and genetic perturbations and link common genetic variation to distinct features of cholesterol-pathway responses.

bioRxiv (Cold Spring Harbor Laboratory)
Broad Institute (US), Howard Hughes Medical Institute (US), Harvard University (US), Purdue University West Lafayette (US)
Broad Institute, National Institutes of Health, Stanley Center for Psychiatric Research, Broad Institute
Good health and well-being
Cholesterol and Lipid Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon